Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
risperidone long acting injectable
DRUG
3 trials
Sponsors
Janssen Pharmaceutica N.V., Belgium
, Janssen Pharmaceutical K.K.
Conditions
Psychotic Disorders
Schizoaffective Disorder
Schizophrenia
Phase 1
A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients
Completed
NCT00653406
Janssen Pharmaceutical K.K.
Schizophrenia
Start: 2002-11-30
End: 2003-10-31
Updated: 2011-05-17
Phase 3
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
Completed
NCT00249223
Janssen Pharmaceutica N.V., Belgium
Psychotic Disorders, Schizophrenia
Start: 2000-01-31
End: 2000-12-31
Updated: 2011-01-14
Phase 4
Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
Completed
NCT00369239
Janssen Pharmaceutica N.V., Belgium
Psychotic Disorders, Schizoaffective Disorder, Schizophrenia
Start: 2006-03-31
End: 2007-11-30
Updated: 2011-05-17